Tissue-Specific Antioxidant Antimutagenesis
Tissue-Specific Antioxidant Antimutagenesis
批准号:
6795939
负责人:
STEVE Seev SOMMER
金额:
$39.38万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2005-08-31
关键词:
age differenceanimal genetic material tagantioxidantsascorbatecancer preventioncarcinogenesiscarotenediet therapydietary constituentdietary supplementsgene frequencygene mutationgene targetinggenetically modified animalslaboratory mousemutagensneoplastic processnutrition related neoplasm /cancernutrition related tagoxidative stressperoxidationtocopherols
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (provided by applicant) The potential impact of antioxidants on
aging and degenerative diseases has been widely recognized in recent years and
billions of dollars are spent annually on megadose antioxidant supplements. The
modem free radical theory of aging postulates a shift in the
antioxidant/pro-oxidant balance that leads to increased oxidative stress,
dysregulation of cellular function, and aging. In the context of this theory,
antioxidants can influence the primary "intrinsic" aging process as well as
several secondary age-associated pathological processes. Several
epidemiological and clinical studies have revealed potential roles for dietary
antioxidants in age-associated autoimmune diseases, and the reduction of risk
of morbidity and mortality from cancer. The Big Blue transgenic mouse mutation
detection system allows the relationship between oxidative stress, mutagenesis,
and carcinogenesis to be examined in a manner not previously possible. The Big
Blue system will be utilized to measure the effects of dietary antioxidants on
mutation frequency and pattern, and tumorigenesis under conditions of normal
and elevated endogenous oxidative stress. The results may provide insight into
the nature and extent of tissue-specific oxidative stress and lay the
foundation for future studies to modify the incidence or progression of
tumorigenesis. The results will have implications for our understanding
spontaneous somatic mutation in humans and for defining the maximal
antimutagenic effect of vitamin E, C and beta-carotene supplements separately
or in cocktails.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1093/hmg/ddn190
发表时间:
2008-09
期刊:
Human molecular genetics
影响因子:
3.5
作者:
[W. Scaringe;Kai Li;D. Gu;K. Gonzalez;Zhenbin Chen;K. Hill;S. Sommer]
通讯作者:
W. Scaringe;Kai Li;D. Gu;K. Gonzalez;Zhenbin Chen;K. Hill;S. Sommer
Preferential occurrence of 1-2 microindels.
优先出现 1-2 个微插入缺失。
DOI:
10.1002/humu.20260
发表时间:
2006
期刊:
Human mutation
影响因子:
3.9
作者:
[Hill,KathleenA, Gonzalez,KellyD, Scaringe,WilliamA, Wang,Ji-Cheng, Sommer,SteveS]
通讯作者:
Sommer,SteveS
Monitoring of Therapy or Recurrence in Breast Cancer with Cancer-specific Mutatio
-
批准号:8004537
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2010
-
负责人:STEVE Seev SOMMER
-
依托单位:
Highly-Multiplexed Accurate HLA Typing using PAP and Digital Bead Technologies
-
批准号:7053472
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2006
-
负责人:STEVE Seev SOMMER
-
依托单位:
Restoration of Factor VIII/IX Function in Hemophilia A/B Patients with Nonsense
-
批准号:7040111
-
项目类别:
-
资助金额:$0.21万
-
财政年份:2003
-
负责人:STEVE Seev SOMMER
-
依托单位:
Aging and Mutation Load in Transgenic Medaka Fish
-
批准号:6477868
-
项目类别:
-
资助金额:$8.75万
-
财政年份:2002
-
负责人:STEVE Seev SOMMER
-
依托单位:
Artificial Nanotube Gels for Mutation Detection
-
批准号:6622151
-
项目类别:
-
资助金额:$14.51万
-
财政年份:2002
-
负责人:STEVE Seev SOMMER
-
依托单位:
Carbon Nanotubes: Artifical Gels for Mutations Detection
-
批准号:6440122
-
项目类别:
-
资助金额:$16.28万
-
财政年份:2002
-
负责人:STEVE Seev SOMMER
-
依托单位:
PAP: a technology platform
-
批准号:6953715
-
项目类别:
-
资助金额:$63.31万
-
财政年份:2002
-
负责人:STEVE Seev SOMMER
-
依托单位:
PAP: a technology platform
-
批准号:6548992
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2002
-
负责人:STEVE Seev SOMMER
-
依托单位:
Translational Bypass in Patients with Hemophilia
-
批准号:6656856
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2002
-
负责人:STEVE Seev SOMMER
-
依托单位:
PAP: a technology platform
-
批准号:7110242
-
项目类别:
-
资助金额:$62.55万
-
财政年份:2002
-
负责人:STEVE Seev SOMMER
-
依托单位:
Translational Bypass in Patients with Hemophilia
-
批准号:6464855
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2002
-
负责人:STEVE Seev SOMMER
-
依托单位:
PAP: a technology platform
-
批准号:6933957
-
项目类别:
-
资助金额:$62.34万
-
财政年份:2002
-
负责人:STEVE Seev SOMMER
-
依托单位:
Tissue-Specific Antioxidant Antimutagenesis
-
批准号:6533936
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2001
-
负责人:STEVE Seev SOMMER
-
依托单位:
Tissue-Specific Antioxidant Antimutagenesis
-
批准号:6648483
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2001
-
负责人:STEVE Seev SOMMER
-
依托单位:
Tissue-Specific Antioxidant Antimutagenesis
-
批准号:6369018
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2001
-
负责人:STEVE Seev SOMMER
-
依托单位:
FACTORS AFFECTING SOMATIC MUTATION--FOCUS ON THE BRAIN
-
批准号:2272125
-
项目类别:
-
资助金额:$13.32万
-
财政年份:1996
-
负责人:STEVE Seev SOMMER
-
依托单位:
FACTORS AFFECTING SOMATIC MUTATION--FOCUS ON THE BRAIN
-
批准号:6187998
-
项目类别:
-
资助金额:$38.28万
-
财政年份:1996
-
负责人:STEVE Seev SOMMER
-
依托单位:
FACTORS AFFECTING SOMATIC MUTATION--FOCUS ON THE BRAIN
-
批准号:2891946
-
项目类别:
-
资助金额:$36.81万
-
财政年份:1996
-
负责人:STEVE Seev SOMMER
-
依托单位:
FACTORS AFFECTING SOMATIC MUTATION--FOCUS ON THE BRAIN
-
批准号:2685705
-
项目类别:
-
资助金额:$35.39万
-
财政年份:1996
-
负责人:STEVE Seev SOMMER
-
依托单位:
FACTORS AFFECTING SOMATIC MUTATION--FOCUS ON THE BRAIN
-
批准号:2502973
-
项目类别:
-
资助金额:$34.03万
-
财政年份:1996
-
负责人:STEVE Seev SOMMER
-
依托单位: